Aegea raises $13.3 million for endometriosis
This article was originally published in Scrip
Executive Summary
AEGEA Medical, developer of a novel, minimally invasive treatment for abnormal uterine bleeding, has completed a $13.3 million private equity financing led by Covidien Ventures and including existing investors Alloy Ventures and Delphi Ventures. Amy Belt, Director of Covidien Ventures, has joined AEGEA's board of directors.